U.S., Dec. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07285018) titled 'A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain' on Dec. 09.
Brief Summary: The purpose of this study is to test the safety and efficacy of study drug LY4065967 for the treatment of diabetic peripheral neuropathic pain (DPNP). This trial is part of the chronic pain master protocol H0P-MC-CPMP (NCT05986292) which is a protocol to accelerate the development of new treatments for chronic pain.
Study Start Date: Dec., 2025
Study Type: INTERVENTIONAL
Condition:
Diabetic Peripheral Neuropathic Pain
Intervention:
DRUG: LY4065967
Administered orally
DRUG: Placebo...